Business Brief -- Roberts Pharmaceutical Corp.:
   Expansion Includes Purchase
   Of Clinical Research Centers
The transaction is the latest by Roberts in an aggressive
expansion effort that has included buying rights to other
companies' drugs and selling a significant stake to Japan's
Yamanouchi Pharmaceutical Ltd.
   In national over-the-counter trading yesterday afternoon,
Roberts shares were quoted at $34.75, up 25 cents.